Dow +0.18 %
22381pts, Nasdaq+0.00 % a 6453pts , S&P+ 0.12% 2510pts
$ZYNE |
|
|
|
|
|
|
Zynerba
Pharmaceuticals Inc |
|
|
|
|
|
Industria:Farmacéutica |
|
|
|
|
|
Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
$ZYNE subio 52.67% a $9.45 luego de anunciar un psoitivo estudio sobre cannabis
medicinal
$DXCM |
|
|
|
|
|
|
DexCom |
|
|
|
|
|
|
Industria:
Laboratorios Mèdicos |
|
|
|
|
Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
$DXCM bajo 32.78 % a $45.35 luego de que la FDA aprobara plicación de glucosa para Abbot
competencia |
directa de
$DXCM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Otros Stocks: |
|
|
|
|
|
$ZYNE
, $EXA , $BYBK , $AMMA , $ITUS , $PME , $HIIQ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|